Akebia Therapeutics recalls
Akebia Therapeutics has 2 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 24 Feb 2021. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Feb 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why akebia therapeutics is recalled
By year
All akebia therapeutics recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Auryxia (ferric citrate) tablets, 210 mg* recalled | Akebia Therapeutics | Potency & Assay | Nationwide |
| Drug | CLASS II | Auryxia (ferric citrate) tablets, 210 mg recalled by Akebia TherapeuticsAuryxia | Akebia Therapeutics | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.